Top-News
Donnerstag,
08.10.2015 17:20
von
PR Newswire
| Aufrufe: 148
Shareholder Class Action Filed Against Globus Medical, Inc. - GMED
Ein alter Globus (Symbolbild).
© PIRO4D / Pixabay
PR Newswire
RADNOR, Pa., Oct. 8, 2015
RADNOR, Pa., Oct. 8, 2015 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP announces that a shareholder class action lawsuit has been filed against Globus Medical, Inc. (NYSE: GMED) ("Globus Medical" or the "Company") on behalf of purchasers of the Company's securities between February 26, 2014 through August 5, 2014, inclusive (the "Class Period").
Globus Medical shareholders who wish to discuss this action and their legal options are encouraged to contact Kessler Topaz Meltzer & Check, LLP (Darren J. Check, Esq., D. Seamus Kaskela, Esq. or Adrienne O. Bell, Esq.) at (888) 299-7706 or at info@ktmc.com.
For additional information about this lawsuit, or to request information about this action online, please visit http://www.ktmc.com/new-cases/globus-medical-inc.
Globus Medical is a medical device company that develops products to treat patients with musculoskeletal disorders.
The Complaint alleges that Globus Medical and certain of its executive officers made a series of false and misleading statements during the Class Period, and failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, the defendants are alleged to have made false and misleading statements and/or failed to disclose that: (1) Globus Medical's relationship with a significant distributor was deteriorating; (2) such deterioration was negatively impacting Globus Medical's financial performance; and (3) as a result of the foregoing, defendants' statements about Globus Medical's business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.
On August 5, 2014, Globus Medical issued a press release announcing its financial and operational results for the second quarter of 2014, and lowering its revenue guidance for fiscal 2014. On this news, shares of the Company's common stock declined $4.05 per share, or 17.9%, to close on August 6, 2014 at $18.51 per share.
If you wish to discuss this action or have any questions concerning this notice or your rights or interests with respect to these matters, please contact Kessler Topaz Meltzer & Check (Darren J. Check, Esq., D. Seamus Kaskela, Esq. or Adrienne O. Bell, Esq.) at (888) 299 – 7706 or (610) 667 – 7706, or via e-mail at info@ktmc.com
Members of the class may, no later than November 30, 2015, petition the Court for appointment as a lead plaintiff of the class. A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. In order to be appointed as a lead plaintiff, the Court must determine that the class member's claim is typical of the claims of other class members, and that the class member will adequately represent the class in the action. Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff. Any member of the purported class may move the court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member.
Kessler Topaz Meltzer & Check prosecutes class actions in state and federal courts throughout the country. Kessler Topaz Meltzer & Check is a driving force behind corporate governance reform, and has recovered billions of dollars on behalf of institutional and individual investors from the United States and around the world. The firm represents investors, consumers and whistleblowers (private citizens who report fraudulent practices against the government and share in the recovery of government dollars). The complaint in this action was not filed by Kessler Topaz Meltzer & Check. For more information about Kessler Topaz Meltzer & Check, or for additional information about participating in this action, please visit www.ktmc.com.
CONTACT:
Kessler Topaz Meltzer & Check, LLP
Darren J. Check, Esq.
D. Seamus Kaskela, Esq.
Adrienne O. Bell, Esq.
280 King of Prussia Road
Radnor, PA 19087
(888) 299 - 7706
(610) 667 - 7706
info@ktmc.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/shareholder-class-action-filed-against-globus-medical-inc--gmed-300156684.html
SOURCE Kessler Topaz Meltzer & Check, LLP
Werbung
Mehr Nachrichten zur Globus Medical Aktie kostenlos abonnieren
E-Mail-Adresse
Bitte überprüfe deine die E-Mail-Adresse.
Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)
-1
Vielen Dank, dass du dich für unseren Newsletter angemeldet hast. Du erhältst in Kürze eine E-Mail mit einem Aktivierungslink.
Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.
